What sector does Ligand Pharmaceuticals Incorporated (LGND) operate in?
Ligand Pharmaceuticals Incorporated belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Ligand Pharmaceuticals Incorporated (LGND) current stock price?
As of the latest data, Ligand Pharmaceuticals Incorporated stock price is $300.53, with a previous close of $302.15. Ligand Pharmaceuticals Incorporated lost -$1.62 in the last trading session, representing a -0.54% loss.
What is Ligand Pharmaceuticals Incorporated (LGND) current market capitalization?
Ligand Pharmaceuticals Incorporated market cap is approximately 6.02 billion.
What is Ligand Pharmaceuticals Incorporated (LGND) Earnings Per Share (EPS)?
The trailing EPS is $7.68, and the forward EPS is $11.32.
What is Ligand Pharmaceuticals Incorporated (LGND) Price-to-Earnings (P/E) ratio?
Ligand Pharmaceuticals Incorporated current P/E ratio is 39.13, with a forward P/E of 26.56.
What is Ligand Pharmaceuticals Incorporated (LGND) EBITDA?
Ligand Pharmaceuticals Incorporated EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -14.30 million.
Does Ligand Pharmaceuticals Incorporated (LGND) pay dividends?
No. Ligand Pharmaceuticals Incorporated does not pay a dividend.
How did Ligand Pharmaceuticals Incorporated (LGND) perform in its most recent earnings report?
In the last report (March 31, 2026), Ligand Pharmaceuticals Incorporated posted an EPS surprise of -168.37% and a revenue surprise of -12.12%.
When is Ligand Pharmaceuticals Incorporated (LGND) next earnings report?
Ligand Pharmaceuticals Incorporated is expected to release its next earnings report on June 30, 2026.
What is Ligand Pharmaceuticals Incorporated (LGND) beta (volatility) score?
Ligand Pharmaceuticals Incorporated has a beta of 1.039, meaning its volatility is roughly in line with the market.
